Skip to content
Close menu


Panel members, Competition 21, Phase 3, Cardiovascular Disease

Dr Liz Mear (Chair)
Self employed and Non-Executive Director at Health Education England
Dr Liz Mear has about 36 years’ experience in the NHS, local government, academia and working with industry. She was an NHS Chief for about 10 years and held national roles supporting development/deployment of products and services that improve lives. Liz is now a consultant/ coach and supports health/ care businesses to succeed.

Dr Terry Parlett (Deputy Chair)
Commercialisation Director at Cambridge Enterprise Limited
Intellectual Property, Tech-Transfer, Spinouts and Investments, Business Development, Partnerships, Innovation, Medical Devices, Therapeutics, Vaccines, Software, Data, Healthcare and Life Sciences sectors.

Ms Laura Boyd
Director of Implementation at UCL Partners
Innovation spread and adoption; cardiovascular health.

Professor Kennedy Cruickshank
Emeritus Professor at King’s College London
Cardiovascular medicine/ hypertension, arterial function, type 2 diabetes.

Dr Debashish Das
Consultant Cardiologist and Digital Transformation at St Bartholomew’s Hospital and Whipps Cross Hospital
Prevention, diagnosis and treatment of coronary artery disease and heart failure.

Mr Andrew Davies
Digital Health Lead at Association of British Health Tech Industries Ltd
25+ years Commercial/Business Development experience in medical device sector, consumable and capital equipment. In depth knowledge of UK market from role at trade association.

Mr Chris Donnellan
Equity analyst at Cenkos Securities plc
Healthcare equity research and capital markets, broadly across pharma, medtech and biotech.

Mr Keith Errey
Chief Executive Officer at Isansys Lifecare Limited
Wireless physiological sensors; remote patient monitoring systems and services; data-driven predictive indicators; commercialisation of new and translational technologies.

Dr Nausheen Hameed
Health Technology Advisor at UCL Partners
A GP partner with a special interest in Cardiology, clinical commissioning lead for CVD in NEL ICS and Health technology advisor at UCLP.

Dr Des Holden
Medical Director at Kent Surrey Sussex AHSN
Chief of Innovation at Surrey and Sussex Healthcare Trust
Implementation Lead at NIHR ARC Kent Surrey Sussex
Des has 10 years’ experience as an acute hospital medical director and has been with KSS AHSN since first licensed and leads implementation research for the Applied Research Collaboration. He is a Board member of SEHTA and an international advisor to Public Intelligence in Southern Denmark.

Dr Avi Mehra
Co-Founder & Managing Director at Doctorpreneurs Ltd
Work at the intersection of Clinical, Commercial and Technology Fields in Healthcare Industry Digital Health Healthcare Technology.

Professor Stephen Morris
RAND Professor of Health Services Research at University of Cambridge
Health economics, health services research.

Dr Laura Sheard
Associate Professor at University of York
Expertise: An applied health services researcher and qualitative methodologist with an interest in health inequalities, prison healthcare, patient safety, implementation science and macro level systems.

Professor Anthony Wierzbicki
Consultant and honorary professor in metabolic medicine and chemical pathology
Lipids and cardiometabolic disease. Previously a member of the NICE technology and diagnostic appraisal committees, familial hypercholesterolaemia guideline group and chair of the NICE lipid modification guideline.

Dr Anmol Arora
PPIE Representative
Dr Anmol Arora is a public committee member based at the University of Cambridge, with research interests in healthcare applications of artificial intelligence.

Ms Josephine Tapper
PPIE Representative
Josephine provides operational and strategic advice to healthcare providers, academia and industry on embedding PPIE. She was previously panel assessor for the NIHR’s AI award.


Subscribe to the SBRI Healthcare newsletter and receive the latest competition information & latest news updates.